RecruitingNCT01186133

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

Evaluation of Effectiveness and Safety of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice


Sponsor

Seung-Jung Park

Enrollment

50,000 participants

Start Date

Jan 1, 2009

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.


Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with coronary artery disease and percutaneous transluminal coronary angioplasty. The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Korean centres

Multiple Locations, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01186133


Related Trials